WellSaid AI

Unlocking provider access, workflow efficiency, and reimbursement for Dementia Care.

WellSaid AI is an agentic AI platform that helps providers identify cognitive decline earlier, treat it faster, and get reimbursed for care that today goes undocumented.

Physician-founded  ·  NIH-backed  ·  AARP AgeTech Collaborative

See It In Action

WellSaid AI, end to end.

The Problem

Treatment exists. Fewer than 1% of patients get it.

<1%

of patients receive treatment

2,000/day

miss their eligible treatment window

$818B/year

the #1 driver of long-term care spending

Not enough primary care capacity. Too few neurologists. By the time most patients reach a specialist, it's taken 3.5 years — and half of all cases are missed before they ever get that far.

$33B

Every barrier in the patient journey is also an unbilled moment.

$33B a year in provider reimbursement goes uncaptured — not because the codes don't exist, but because the tools to screen, diagnose, and monitor cognitive decline don't fit into a provider's day. WellSaid AI turns each of those barriers into something a care team can actually bill for.

The Patient Journey

We don't stop at screening. WellSaid AI is with the patient at every stage.

From the first sign something's off to ongoing treatment, one platform follows the patient the whole way — not just through a single screening moment.

1

Screening Assessment

An at-home cognitive screen built on vocal biomarkers, completed before the first visit — not a digitized MoCA.

2

Diagnostic Clarity

A comprehensive, specialist-reviewed diagnostic battery completed at home — replacing a 12–18 month neuropsych wait.

3

Lifestyle Coaching & Prevention

Daily coaching grounded in decades of clinical research, across nutrition, movement, brain training, and more.

4

Ongoing Monitoring

At-home efficacy and safety monitoring for patients on treatment, remotely.

The Platform

One agentic AI platform. Four points of access across the patient journey.

01

Early Identification

A scalable cognitive screener, done at home, that replaces the paper-and-pencil MoCA.

02

Comprehensive Evaluation & Diagnosis

A full Brain Health Assessment, self-administered, no waiting for a referral.

03

Prevention & Risk Reduction

An AI companion that coaches the lifestyle habits proven to slow cognitive decline.

04

Ongoing Treatment Monitoring

Remote monitoring for patients on anti-amyloid therapies, between infusion visits.

Proof

Validated by research. Already in the hands of patients and providers.

Clinical Signal

3 NIH awards funding the science

2 more under review

Engagement

23 min/day average

nearly 2x a typical health app

Retention

>95% monthly retention

already in-market and scaling

Institutional Credibility

AARP AgeTech Collaborative

Partners: VCU, Northwestern, Rush, Weill Cornell, Indiana, Miami, Johns Hopkins

“

WellSaid AI's Baseline Cognitive Assessment is intuitive, easy to use, and will help primary care physicians identify subtle cognitive decline earlier and get the right patients referred to neurology sooner.

Dr. John R. Roberts — Chief Medical Officer, Montgomery County Free Clinic

Who We Serve

Built for the organizations closest to the patient.

Primary Care Providers

Turn the Annual Wellness Visit into an early screen, with a clear referral path when something needs a closer look.

Neurologists

Replace a 12–18 month testing backlog with a specialist-reviewed, NIH-validated assessment patients complete at home.

Health Systems

Capture reimbursement across the full cognitive care journey — screening, diagnosis, and monitoring — on one platform that integrates with Epic.

See WellSaid AI in your workflow.

We'll walk you through the platform and show you exactly where it fits — screening, diagnosis, prevention, or monitoring.

Request a Demo